Latest / Boise News Today | 2 Min News | The Daily News Now!
FDA Abortion Drug Rules Under Fire | Boise News
A Virginia federal judge has struck down the FDA’s 2023 restrictions on mifepristone, ruling the agency failed to properly justify rules like prescriber certification and risk disclosures — calling them arbitrary and medically unnecessary. This follows a similar Hawaii court decision, forcing the FDA to revisit its justifications. Abortion care providers celebrate the ruling as a win against burdensome paperwork, freeing up time for patients. Meanwhile, the Biden administration’s 2023 mail-order expansion of mifepristone — which boosted access in restrictive states — continues to face legal…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.